Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Blood pressure and comfort with transcutaneous hypoglossal nerve stimulation using the Zeus Sleep Device

Official title: Assessing Blood Pressure Variability in a Healthy Adult Population During Transcutaneous Hypoglossal Nerve Stimulation With the Zeus Sleep Device

Run by Royal Brompton & Harefield NHS Foundation Trust · NCT07917260 · Data updated 2026-11-12

This study tests whether using the Zeus Sleep Device to stimulate the hypoglossal nerve during sleep is safe in healthy adults and whether it affects blood pressure.

More Transcutaneous Electric Nerve Stimulation trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorRoyal Brompton & Harefield NHS Foundation Trust
Academic / other
Locations1 site (London)
StatusRecruiting
StartedSeptember 29, 2026
Main results expectedFebruary 19, 2027
Study endsMarch 29, 2027
Registry record updatedNovember 4, 2026
Trial IDNCT07917260 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults 18+ in good health with BMI 18.5–29.9 kg/m2, no cardiovascular disease, no contraindications to the Zeus device, and the ability to consent.

Probably not a fit

Patients with cardiovascular disease, hypertension above 140/90 mmHg, arrhythmias, or other contraindications may not benefit and could be at higher risk.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study uses the Zeus Sleep Device to deliver transcutaneous hypoglossal nerve stimulation during sleep in healthy adults. The goal is to characterize any effects on blood pressure while assessing tolerability and safety in a population without obstructive sleep apnea. Participants will have device placement under the chin and will be monitored for cardiovascular and safety outcomes. The trial focuses on short-term exposure and includes clear exclusion criteria to minimize risk. Results will inform whether this approach can be pursued in patients with sleep-disordered breathing without adversely impacting blood pressure.

Why it matters

Potential benefit: If successful, the approach could inform safer use of transcutaneous hypoglossal nerve stimulation for sleep-related breathing issues and guide future patient-directed development.

How similar studies have gone: Previous studies suggest transcutaneous hypoglossal nerve stimulation is feasible and generally well tolerated; this study adds focused evaluation of blood pressure effects in healthy adults.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Adults aged 18 or older
2. Either biological sex
3. Healthy volunteers
4. Able to provide informed consent
5. No contraindications to hypoglossal nerve stimulation using the Zeus device
6. BMI \>18.5 and \<30kg/m2

Exclusion Criteria:

1. Skin allergy, including eczema or allergic contact dermatitis in device placement area
2. Diagnosed heart condition or cardiovascular disease
3. Cardiovascular event in the previous 2 months
4. Implanted medical devices including cardioverter defibrillator and pacemaker
5. Previous or current cardiac arrhythmia
6. Autonomic neuropathy
7. Neuromuscular disease
8. Diagnosed epilepsy or recurrent seizures
9. Hypertension (\>140/90 mmHg)
10. Hypotension (\<95/65 mmHg)
11. Metal work in the head or neck, excluding dental fillings
12. Current migraine
13. Pregnancy
14. Diagnosed or suspected deep vein thrombosis within previous 2 months
15. Recent cancer diagnosis or cancerous legions in proximity to device placement area
16. Alcohol dependence
17. Recent infection requiring hospital admission or medical treatment within the previous month, including leprosy
18. Swollen, inflamed, infected, or broken skin in device placement area
19. Recent surgery within 10 months in, or near, device placement area
20. Currently taking medications, excluding contraceptive medication
21. Long facial hair in device placement area

Where it's running

  • Royal Brompton Hospital
    London, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.